Hormone Therapy, Explained: What You Need to Know After the FDA Decision
The recent FDA decision has created a wave of confusion among clinicians and patients. Practices are fielding questions faster than updated guidance is being disseminated, and misinformation is spreading just as quickly. This session is designed to cut through that noise.
Dr. Robin Noble, a board-certified OB/GYN, Certified Menopause Practitioner, and physician leader with 25 years of clinical experience, will walk clinicians through what the ruling actually means for evidence-based hormone therapy in 2026 and beyond.
What you will learn in the webinar
This live session is part of Perry Academy’s ongoing series on perimenopause care, bringing together experts to translate the latest research into clinical practice.
What changed and what did not
Implications for prescribing across perimenopause and early menopause
How to interpret safety data and communicate it accurately
Common patient misconceptions and how to correct them without over- or under-promising
Practical guidance for real-world cases you’re already seeing in clinic
02 — the ECOSYSTEM